Inventor · disambiguated record
Miguel Sena Esteves
Also filed as: ESTEVES MIGUEL SENA
13 granted patents·7 pending applications·28 citations·filing 2015–2024
87Inventor score
Top patents by PatentIndex Score
20 records- 0194US10370432B2Heterologous targeting peptide grafted AAVSUNIV MASSACHUSETTS·Filed 2015·Granted Aug 6, 2019·18 cites·18 claims
- 0292US11401531B2AAV vectors encoding NF1 and uses thereofUNIV MASSACHUSETTS·Filed 2021·Granted Aug 2, 2022·2 cites·29 claims
- 0384US11014976B2Heterologous targeting peptide grafted AAVSUNIV MASSACHUSETTS·Filed 2019·Granted May 25, 2021·2 cites·17 claims
- 0481US10711270B2High efficiency library-identified AAV vectorsUNIV MASSACHUSETTS·Filed 2015·Granted Jul 14, 2020·2 cites·4 claims
- 0577US11472848B2AAV capsids identified by in vivo library selectionUNIV MASSACHUSETTS·Filed 2019·Granted Oct 18, 2022·1 cites·20 claims
- 0676US11020443B2Modulation of AAV vector transgene expressionUNIV MASSACHUSETTS·Filed 2016·Granted Jun 1, 2021·3 cites·13 claims
- 0774US2025034555A1High efficiency library-identified aav vectorsUNIV MASSACHUSETTS·Filed 2024·Application pending·0 cites
- 0872US12291719B2Heterologous targeting peptide grafted AAVsUNIV MASSACHUSETTS·Filed 2021·Granted May 6, 2025·0 cites·17 claims
- 0971US12077562B2AAV capsids identified by in vivo library selectionUNIV MASSACHUSETTS·Filed 2022·Granted Sep 3, 2024·0 cites·11 claims
- 1071US2023416779A1Self-regulating aav vectors for safe expression of mecp2 in rett syndromeUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 1169US2024139340A1Method to enhance the efficiency of systemic aav gene delivery to the central nervous systemUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 1267US12448629B2rAAV vectors for the treatment of GM1 and GM2 gangliosidosisUNIV MASSACHUSETTS·Filed 2019·Granted Oct 21, 2025·0 cites·19 claims
- 1363US12091659B2High efficiency library-identified AAV vectorsUNIV MASSACHUSETTS·Filed 2020·Granted Sep 17, 2024·0 cites·5 claims
- 1462US11680275B2Self-regulating AAV vectors for safe expression of MeCP2 in rett syndromeUNIV MASSACHUSETTS·Filed 2018·Granted Jun 20, 2023·0 cites·22 claims
- 1560US2025388697A1Anti-sod1 nanobodiesUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 1659US12486518B2Bicistronic AAV vectors encoding hexosaminidase alpha and beta-subunits and uses thereofUNIV MASSACHUSETTS·Filed 2019·Granted Dec 2, 2025·0 cites·10 claims
- 1756US11826433B2Method to enhance the efficiency of systemic AAV gene delivery to the central nervous systemUNIV MASSACHUSETTS·Filed 2017·Granted Nov 28, 2023·0 cites·5 claims
- 1855US2023279405A1Dna-binding domain transactivators and uses thereofUNIV MASSACHUSETTS·Filed 2021·Application pending·0 cites
- 1954US2025135033A1Compositions and methods for treating sialidosisUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 2045US2021228739A1Raav vectors encoding of lysosomal beta-galactosidase (glb1) and cathepsin aUNIV OF MASSACHUSETT·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Miguel Sena Esteves files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →